Original ArticleAdherence and persistence to ropinirole, Pramipexole (cas 104632-26-0), and gabapentin in patients with newly diagnosed restless legs syndrome

Add time:08/22/2019    Source:sciencedirect.com

Study objectivesThe objective of this study is to assess adherence and persistence of ropinirole, pramipexole, and gabapentin; to investigate factors associated with non-adherence and non-persistence in restless legs syndrome (RLS) patients.

We also recommend Trading Suppliers and Manufacturers of Pramipexole (cas 104632-26-0). Pls Click Website Link as below: cas 104632-26-0 suppliers

Prev:Full paperNeuroprotective effects of Pramipexole (cas 104632-26-0) transdermal patch in the MPTP-induced mouse model of Parkinson's disease
Next:Renal tubular secretion of pramipexole)